392 related articles for article (PubMed ID: 21600812)
1. Prevalence of polycystic ovarian syndrome in Indian adolescents.
Nidhi R; Padmalatha V; Nagarathna R; Amritanshu R
J Pediatr Adolesc Gynecol; 2011 Aug; 24(4):223-7. PubMed ID: 21600812
[TBL] [Abstract][Full Text] [Related]
2. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
Hassa H; Tanir HM; Yildiz Z
Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
[TBL] [Abstract][Full Text] [Related]
3. A simple screening approach for assessing community prevalence and phenotype of polycystic ovary syndrome in a semi-urban population in Sri Lanka.
Kumarapeli V; Seneviratne Rde A; Wijeyaratne CN; Yapa RM; Dodampahala SH
Am J Epidemiol; 2008 Aug; 168(3):321-8. PubMed ID: 18550559
[TBL] [Abstract][Full Text] [Related]
4. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria.
March WA; Moore VM; Willson KJ; Phillips DI; Norman RJ; Davies MJ
Hum Reprod; 2010 Feb; 25(2):544-51. PubMed ID: 19910321
[TBL] [Abstract][Full Text] [Related]
5. High Prevalence of Polycystic Ovary Syndrome in Type 1 Diabetes Mellitus Adolescents: Is There a Difference Depending on the NIH and Rotterdam Criteria?
Busiah K; Colmenares A; Bidet M; Tubiana-Rufi N; Levy-Marchal C; Delcroix C; Jacquin P; Martin D; Benadjaoud L; Jacqz-Aigrain E; Laborde K; Robert JJ; Samara-Boustani D; Polak M
Horm Res Paediatr; 2017; 87(5):333-341. PubMed ID: 28437788
[TBL] [Abstract][Full Text] [Related]
6. Polycystic ovary syndrome: a common but often unrecognized condition.
Shannon M; Wang Y
J Midwifery Womens Health; 2012; 57(3):221-30. PubMed ID: 22594862
[TBL] [Abstract][Full Text] [Related]
7. The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome.
Amato MC; Galluzzo A; Finocchiaro S; Criscimanna A; Giordano C
Clin Endocrinol (Oxf); 2008 Jul; 69(1):52-60. PubMed ID: 18034780
[TBL] [Abstract][Full Text] [Related]
8. Primary amenorrhea as a manifestation of polycystic ovarian syndrome in adolescents: a unique subgroup?
Rachmiel M; Kives S; Atenafu E; Hamilton J
Arch Pediatr Adolesc Med; 2008 Jun; 162(6):521-5. PubMed ID: 18524741
[TBL] [Abstract][Full Text] [Related]
9. Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome.
Hart R; Hickey M; Franks S
Best Pract Res Clin Obstet Gynaecol; 2004 Oct; 18(5):671-83. PubMed ID: 15380140
[TBL] [Abstract][Full Text] [Related]
10. [Sertoli-Leydig cell tumour (arrhenoblastoma) in a patient with polycystic ovary syndrome: clinical, ultrasonographic, hormonal and histopathological evaluation].
Puzigaća S; Prelević G; Svetenović Z; Djuricić S; Kokan Dj; Radivojević U
Srp Arh Celok Lek; 2001; 129 Suppl 1():51-5. PubMed ID: 15637992
[TBL] [Abstract][Full Text] [Related]
11. Hirsutism and oligomenorrhea are appropriate screening criteria for polycystic ovary syndrome in adolescents.
Villarroel C; López P; Merino PM; Iñiguez G; Sir-Petermann T; Codner E
Gynecol Endocrinol; 2015; 31(8):625-9. PubMed ID: 26190534
[TBL] [Abstract][Full Text] [Related]
12. Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome.
Barber TM; Wass JA; McCarthy MI; Franks S
Clin Endocrinol (Oxf); 2007 Apr; 66(4):513-7. PubMed ID: 17371468
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and characteristics of the polycystic ovary syndrome in overweight and obese women.
Alvarez-Blasco F; Botella-Carretero JI; San Millán JL; Escobar-Morreale HF
Arch Intern Med; 2006 Oct; 166(19):2081-6. PubMed ID: 17060537
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of polycystic ovary syndrome in young women who had idiopathic central precocious puberty.
Franceschi R; Gaudino R; Marcolongo A; Gallo MC; Rossi L; Antoniazzi F; Tatò L
Fertil Steril; 2010 Mar; 93(4):1185-91. PubMed ID: 19135667
[TBL] [Abstract][Full Text] [Related]
15. An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome.
Brzozowska MM; Ostapowicz G; Weltman MD
J Gastroenterol Hepatol; 2009 Feb; 24(2):243-7. PubMed ID: 19215335
[TBL] [Abstract][Full Text] [Related]
16. A comparison of bone mineral density in normal weight and obese adolescents with polycystic ovary syndrome.
To WW; Wong MW
J Pediatr Adolesc Gynecol; 2012 Aug; 25(4):248-53. PubMed ID: 22840935
[TBL] [Abstract][Full Text] [Related]
17. Impact of electro-acupuncture and physical exercise on hyperandrogenism and oligo/amenorrhea in women with polycystic ovary syndrome: a randomized controlled trial.
Jedel E; Labrie F; Odén A; Holm G; Nilsson L; Janson PO; Lind AK; Ohlsson C; Stener-Victorin E
Am J Physiol Endocrinol Metab; 2011 Jan; 300(1):E37-45. PubMed ID: 20943753
[TBL] [Abstract][Full Text] [Related]
18. The Diagnostic Value of Anti-Müllerian Hormone in Early Post Menarche Adolescent Girls with Polycystic Ovarian Syndrome.
Kocaay P; Siklar Z; Buyukfirat S; Berberoglu M
J Pediatr Adolesc Gynecol; 2018 Aug; 31(4):362-366. PubMed ID: 29462707
[TBL] [Abstract][Full Text] [Related]
19. Clinical and biochemical presentations of polycystic ovary syndrome among obese and nonobese women.
Liou TH; Yang JH; Hsieh CH; Lee CY; Hsu CS; Hsu MI
Fertil Steril; 2009 Dec; 92(6):1960-5. PubMed ID: 18980763
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of polycystic ovary syndrome in girls aged 14-18 years in Isfahan, Iran.
Hashemipour M; Faghihimani S; Zolfaghary B; Hovsepian S; Ahmadi F; Haghighi S
Horm Res; 2004; 62(6):278-82. PubMed ID: 15523185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
